Total Payments
$2,507
2022 Payments
$45.51
Companies
19
Transactions
95
Medicare Patients
1,374
Medicare Billing
$89,655
Payment Breakdown by Category
Food & Beverage$1,395 (55.6%)
Travel$872.28 (34.8%)
Education$239.99 (9.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,395 | 90 | 55.6% |
| Travel and Lodging | $872.28 | 2 | 34.8% |
| Education | $239.99 | 3 | 9.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| NeoTract Inc. | $917.15 | 4 | $0 (2020) |
| Astellas Pharma US Inc | $585.87 | 36 | $0 (2022) |
| AbbVie Inc. | $193.58 | 7 | $0 (2021) |
| Endo Pharmaceuticals Inc. | $166.06 | 12 | $0 (2021) |
| Janssen Biotech, Inc. | $124.43 | 4 | $0 (2021) |
| Bayer HealthCare Pharmaceuticals Inc. | $120.20 | 6 | $0 (2022) |
| PFIZER INC. | $89.86 | 6 | $0 (2019) |
| Allergan, Inc. | $70.34 | 5 | $0 (2021) |
| Myovant Sciences Inc. | $38.88 | 3 | $0 (2021) |
| C. R. Bard, Inc. & Subsidiaries | $33.29 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $45.51 | 3 | 180 Medical, Inc. ($18.05) |
| 2021 | $247.16 | 18 | Astellas Pharma US Inc ($56.12) |
| 2020 | $351.85 | 20 | Janssen Biotech, Inc. ($97.34) |
| 2019 | $273.38 | 21 | Astellas Pharma US Inc ($132.76) |
| 2018 | $1,351 | 23 | NeoTract Inc. ($903.96) |
| 2017 | $238.33 | 10 | Astellas Pharma US Inc ($153.19) |
All Payment Transactions
95 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/17/2022 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: Oncology | ||||||
| 03/10/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: Urology | ||||||
| 01/26/2022 | 180 Medical, Inc. | GENTLECATH (Device) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: CONTINENCE CARE | ||||||
| 12/09/2021 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | Cash or cash equivalent | $11.56 | General |
| Category: Urology | ||||||
| 09/29/2021 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological), LYNPARZA, WELIREG | Food and Beverage | In-kind items and services | $11.55 | General |
| Category: ONCOLOGY | ||||||
| 07/21/2021 | Myovant Sciences Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: HORMONE THERAPY | ||||||
| 07/14/2021 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: Oncology | ||||||
| 06/29/2021 | C. R. Bard, Inc. & Subsidiaries | — | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Medical Systems | ||||||
| 06/23/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: UROLOGY | ||||||
| 06/09/2021 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological), EDEX, AVEED | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: UROLOGY | ||||||
| 05/26/2021 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: Oncology | ||||||
| 05/18/2021 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Oncology | ||||||
| 05/04/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $11.85 | General |
| Category: UROLOGY | ||||||
| 04/20/2021 | Myovant Sciences Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $12.19 | General |
| Category: HORMONE THERAPY | ||||||
| 04/15/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: UROLOGY | ||||||
| 04/07/2021 | Axonics, Inc. | Axonics r-SNM System (Device) | Food and Beverage | In-kind items and services | $11.97 | General |
| Category: Urology | ||||||
| 03/16/2021 | AbbVie Inc. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/12/2021 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological), EDEX, AVEED | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: UROLOGY | ||||||
| 02/05/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: UROLOGY | ||||||
| 01/19/2021 | Myovant Sciences Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $12.53 | General |
| Category: HORMONE THERAPY | ||||||
| 01/14/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: HYPERHYDROSIS | ||||||
| 12/17/2020 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological), EDEX, AVEED | Food and Beverage | In-kind items and services | $12.65 | General |
| Category: UROLOGY | ||||||
| 12/08/2020 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $12.95 | General |
| 12/03/2020 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: UROLOGY | ||||||
| 11/11/2020 | AbbVie Inc. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 7 | 226 | 262 | $57,451 | $7,577 |
| 2021 | 8 | 544 | 723 | $161,238 | $33,557 |
| 2020 | 10 | 604 | 939 | $196,137 | $48,522 |
Total Patients
1,374
Total Services
1,924
Medicare Billing
$89,655
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 58 | 65 | $9,555 | $2,644 | 27.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 42 | 42 | $8,946 | $1,900 | 21.2% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 11 | 12 | $14,796 | $1,307 | 8.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 23 | 30 | $3,450 | $942.87 | 27.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 12 | 12 | $2,808 | $409.47 | 14.6% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2022 | 48 | 63 | $2,772 | $252.38 | 9.1% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 32 | 38 | $15,124 | $121.27 | 0.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 112 | 169 | $24,843 | $10,008 | 40.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 97 | 108 | $23,004 | $9,357 | 40.7% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2021 | 31 | 36 | $44,388 | $5,975 | 13.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 50 | 50 | $11,700 | $3,974 | 34.0% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 53 | 69 | $7,935 | $2,758 | 34.8% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2021 | 108 | 160 | $7,040 | $643.20 | 9.1% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2021 | 77 | 101 | $40,198 | $639.93 | 1.6% |
| 74018 | X-ray of abdomen, 1 view | Office | 2021 | 16 | 30 | $2,130 | $201.26 | 9.4% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2020 | 12 | 116 | $31,668 | $19,794 | 62.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 135 | 192 | $28,224 | $9,781 | 34.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 102 | 105 | $22,365 | $6,523 | 29.2% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2020 | 30 | 34 | $41,922 | $5,047 | 12.0% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 63 | 100 | $11,500 | $3,144 | 27.3% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 30 | 30 | $7,020 | $2,236 | 31.9% |
| 81000 | Manual urinalysis test with examination using microscope | Office | 2020 | 129 | 210 | $9,240 | $838.92 | 9.1% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2020 | 65 | 96 | $38,208 | $587.16 | 1.5% |
| 96402 | Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle | Office | 2020 | 12 | 19 | $3,363 | $340.20 | 10.1% |
| 74018 | X-ray of abdomen, 1 view | Office | 2020 | 26 | 37 | $2,627 | $230.16 | 8.8% |
About Dr. John Fuller, MD
Dr. John Fuller, MD is a Urology healthcare provider based in Stevens Point, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801817267.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Fuller, MD has received a total of $2,507 in payments from pharmaceutical and medical device companies, with $45.51 received in 2022. These payments were reported across 95 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,395).
As a Medicare-enrolled provider, Fuller has provided services to 1,374 Medicare beneficiaries, totaling 1,924 services with total Medicare billing of $89,655. Data is available for 3 years (2020–2022), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Stevens Point, WI
- Active Since 07/21/2006
- Last Updated 12/29/2021
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1801817267
Products in Payments
- UroLift (Device) $917.15
- MYRBETRIQ (Drug) $266.92
- XIAFLEX (Biological) $166.06
- XTANDI (Drug) $158.78
- Lupron (Drug) $140.05
- ERLEADA (Drug) $110.34
- Nubeqa (Drug) $71.80
- Myrbetriq (Drug) $65.25
- BOTOX (Biological) $49.28
- Essure (Device) $48.40
- LUPRON DEPOT (Drug) $40.58
- ORGOVYX (Drug) $38.88
- Rezum (Device) $30.23
- KEYTRUDA (Biological) $26.58
- Urgent PC (Device) $23.39
- GENTLECATH (Device) $18.05
- BMD-Endobeam Laser Fibers (Device) $17.51
- SUTENT (Drug) $17.32
- REZUM (Device) $15.38
- Erleada (Drug) $14.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.